The two can be used concurrently, with some practitioners recommending BPC-157 both before and after PRP treatment to optimize the tissue environment for growth factor activity
Cas des solutions fluorescentes
Patients with cancer history, autoimmune conditions, pregnancy, severe cardiovascular issues, or known peptide sensitivities should not use this therapy
10.1038/s41386-019-0411-y 28 RourkeE.LawF
The bottom line is that BPC-157 has real therapeutic potential, but that potential is best realized within a medically supervised framework that prioritizes safety, quality, and individualized care
Realistic timeline based on preclinical data and community reports